News

The use of intravitreal dexamethasone (IVD) is not warranted as a routine adjunctive treatment in postoperative endophthalmitis.

People who are dissatisfied with the results of LASIK are more likely to be referred to a cornea service by their doctor than by their LASIK surgeon.

Ophthalmologists in more than 34 countries around the globe are busy planning events for World Glaucoma Day on March 6th to alert people to the devastating effects of glaucoma and the importance of having their eyes examined.

With increasing numbers of patients undergoing filtration surgery with the Ex-PRESS Miniature Glaucoma devices (Optonol), anterior segment surgeons should be aware of the potential for device exposure.

Glaucoma may be associated with an increased rate of mortality in adults.

A single intravitreal injection of the fusion protein KH902 can effectively inhibit leakage and growth of choroidal neovascularization in rhesus monkeys.

The persistence of intraocular pressure (IOP) elevation following treatment with intravitreal triamcinolone acetonide (IVTA) means that it should only be used after careful consideration.

Polarisation-sensitive optical coherence tomography (PS-OCT) is a promising new tool for diagnosis, disease follow-up and the evaluation of new treatment strategies in disease affecting the retinal pigment epithelium .

March 08 Editorial List

Genentech has resolved its dispute with American ophthalmologists over the off-label use of its anti-VEGF drug Avastin, and will now allow physicians to purchase the drug directly from authorized wholesale distributors.

Topical nonsteroidal anti-inflammatory drugs often are administered for off-label purposes to patients who are undergoing cataract surgery, but surgeons should consider the cost, the risks, and the evidence available to support such use.

The Simplified Age-Related Eye Disease Study (AREDS) Age-Related Macular Degeneration (AMD) Severity Scale has been shown to be predictive of vision loss.

Microincision cataract surgery (MICS) does not degrade the optical quality of the cornea or induce a modification in corneal astigmatism.

Triple therapy for age-related macular degeneration (AMD) can stabilize vision and reduce the re-treatment rate in patients who do not respond to initial anti-VEGF therapy.

A half-top-hat wound configuration is a valid option for penetrating keratoplasty (PK) as it offers better apposition of donor and recipient corneas, improved tectonic strength and the possibility of early suture removal.

LASIK for myopia over -10 D is both safe and effective in the long-term.

Pigment-epithelium-derived factor (PEDF), which is known for its importance in the prevention of neovascularization of the retina, can be found in measurable amounts in the human tear fluid of healthy subjects. It may therefore be important in the regulation of corneal vascularization.

Glaucomatous patients can safely obtain self-tonometry measurements after applying a topical anaesthetic to their eye.

Cells at the back of the eyes of profoundly blind people monitor light levels and use them to set the body's clock to either day or night.

Two transporters that deliver alternative energy sources to the eye may help delay the retinal damage that occurs in diabetes.

Conductive keratoplasty (CK) is an effective long-term treatment for near-plano presbyopia.

Escalating treatment for glaucoma patients who have undergone penetrating keratoplasty (PK) significantly increases the risk of graft failure and poor visual outcomes.

People with low vision can improve their ability to watch television with a new technique that allows them to enhance the contrast of images of people and objects of interest on their digital televisions.

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

The US ophthalmic market will embrace the use of premium intraocular lenses (IOLs) rapidly, whereas less flexible reimbursement programmes in Europe and Japan will delay their adoption in those markets.

A gene, which also behaves as a cancer precursor, has also been found to play a central role in the coordination of retinal proliferation and eye growth during foetal development.

Novagali Pharma's Investigational New Drug Application (IND) to conduct Phase I clinical trials of its Nova63035, for the treatment of diabetic macular oedema (DME), has been granted by the FDA.

Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.

A day in the life

newsletter images